Post by
Whydunnit on Dec 16, 2020 11:20am
PYR's TSX uplist example
This might be a little fuzzy on some of the details, but when PYR uplisted to the TSX as a tech company one of the requirements was that they needed $10M in the treasury, at least half of which had to be from a share issuance. PYR hadn't done an issuance for years and years so it didn't have that. Whether or not they had $10M was kind of secondary -- they needed the share issuance part to qualify for listing. So they did an offering (via oversubscribed bought deal with Mackie IIRC) and were uplisted. (There's some uncertainty about whether or not the TSX has them listed as a tech or industrial, and whether that is just a paperwork oversight.) I'm assuming KNR is wanting to uplist to TSX as a tech company, given they're changing their name from Energy to Technologies. If so, presumably they would need the same $10M/half from share issuance that PYR did. Not an option but a requirement. If the company sticks to its policy of minimal dilution, they'd want the market share price as high as possible (fewer new shares needed for $5M + $1) and not want an oversubscription. Whoever handles the issue for them is going to take a cut too, lowering KNR's take. Hopefully KNR can meet the requirement (if necessary) with just a million new shares, but the stock price would need to be somewhere in the area of $5.50 when the deal is signed.
Comment by
JohnFriesen on Dec 16, 2020 12:48pm
This post has been removed in accordance with Community Policy
Comment by
Mechanizm on Dec 16, 2020 2:31pm
Haven't you heard? If it's to help Covid then everything gets pushed through and rules don't matter... I must have been dreaming. KNR doesn't have the lobby power of pharma.
Comment by
yearninyank on Dec 17, 2020 8:30am
Wait, what... criticizing Big Pharma? But didn't they sacrifice everything to save us from this pandemic with their magic and free vaccine? I heard they really took a loss but they felt it was worth it. Wait, what?
Comment by
HTNYC1 on Dec 16, 2020 2:58pm
My apologies. I was talking about the Nasdaq. Perhaps it is more helpful now.